Introduction
Surface plasmon resonance (SPR) technology is one of the powerful analytical techniques for directly monitoring molecular interactions, without the need for intrinsic or extrinsic labeling to the target molecules, because the phenomenon of SPR is very sensitive against the changes in refractive index on the sensor surface caused by changes in mass between the molecules. [1] [2] [3] [4] Recently, SPR technology has been widely used for the in vitro estimation of drug-biological molecular interactions, for example, drug-proteins and drug-lipid membranes. The data of molecular interactions obtained by SPR systems could be used for the analysis of the mechanisms of the interactions occurred in vivo related to the activity of drugs. In order to reliably estimate drug-biological molecular interactions using the SPR system, we think that suitable assay conditions for the SPR method should established for both weakly soluble compounds and highly soluble compounds, considering drug development from drug substances to drug products.
Amphotericin B (AmB, Fig. 1 ), an antifungal polyene macrolide antibiotic produced by Streptomyces nodosus, is known as a highly hydrophobic, water-insoluble molecule with amphiphilic properties. It was introduced to combat systemic fungal infections in 1959. Since then, AmB has been used in the clinic and is still regarded as a golden standard and a life-saving drug in the treatment of many severe fungal infections. 5 However, AmB treatment requires hospitalization and has numerous side effects, such as a potential nephrotoxicity. [6] [7] [8] Therefore, the development of new antifungal antibiotics is desired for easier treatment and alleviation of these side effects. Attempts have been made to develop various formulations to new drug products based on AmB. The first formulation of AmB, Fungizone, [9] [10] [11] [12] [13] addressed the solubility problem by incorporating AmB in deoxycholate micelles, 14 but the addition of bile salt posed the problem of additional toxicity. The high concentration of surfactant caused membrane damage in red blood cells, 15 and side effects such as diarrhea were observed in patients after oral administration of Fungizone and were attributed to the presence of the detergent sodium deoxycholate. In the present study, we developed an assay of interactions of amphotericin B (AmB) deoxycholate, Fungizone, with two model lipid membranes that mimicked mammal cell membranes and fungal membranes. We also analyzed the binding kinetics of the mammal cell membranes and fungal membranes using surface plasmon resonance (SPR). Fungizone showed a higher affinity for the model fungal membrane than that of the model mammal cell membrane, and the binding selectivity of Fungizone in the temperature dependence could be represented by this SPR system. This method also showed reproducible immobilization of model liposome membranes on the sensor chip under two temperature conditions (25 and 37 C). The binding characteristics of the medicinal additive of Fungizone, sodium deoxycholate, were clarified on the assay of interactions of the drug product to the lipid membrane, and it was confirmed that the sodium deoxycholate did not affect the estimation of membrane selectivity of Fungizone. Furthermore, the affinities of AmB and Fungizone were discussed by comparing these affinity constants. The results demonstrate that this newly established SPR method could be applied to estimate the lipid-membrane interaction of Fungizone as a drug product of AmB. biosensors. [19] [20] [21] [22] [23] [24] [25] Recently, we developed an assay of interactions of AmB with two model lipid membranes. 26 In this study, the binding kinetics of AmB to the membrane could be analyzed by multiple sensorgrams obtained at different AmB concentrations, indicating that the affinity of AmB for ergosterol-containing lipid membranes was approximately 18-fold higher than that for cholesterol-containing lipid membranes. This higher affinity was attributed primarily to the slower dissociation of AmB from the ergosterol-containing lipid membrane than from the cholesterol-containing lipid membrane.
Lipid
These results demonstrate that the established SPR method can be a valuable tool for predicting the selective binding and antimycotic activity of antifugals. Our final target is to develop a tool for predicting the selective binding to lipid membranes and the antifungal activity of antifungal drugs in vivo with the SPR system, including the toxicity properties of the target compounds. Also, we think it is very important to develop a reliable and reproducible SPR method for the precise estimation of interactions in vitro, seen that the reliable and reproducible data could increase the prediction accuracy of drug actions that occur in vivo.
This paper describes an investigation of the lipid membranebinding properties of Fungizone, as a drug product of AmB, with two model lipid membranes, using the established SPR technique of estimation of antifungal drug-lipid membrane interactions. 26 We also estimated the reliability and reproducibility of the established method and revealed the characteristics of temperature dependence of Fungizone binding to the model lipid membranes. Furthermore, we discussed the properties of lipid membrane affinity of Fungizone as a drug product, compared to those of AmB as a drug substance reported previously. 26 We think the assessment method for predicting the effective action of a drug and its side effects should be evaluated based on the drug substance that patients take in the treatment.
Experimental

Reagents and chemicals
Chloroform 
Apparatus
The SPR system used was a BIACORE S51 analytical system and Series S Sensor Chip L1 used for immobilization of liposomes (GE Healthcare UK Ltd., England). The running buffers used were PBS for immobilization of lipid membranes on the chip and the estimation of interactions of the Fungizone with the membrane. The washing solution was 20 mmol/L CHAPS and the regeneration solution was 100 mmol/L HCl/2-propylalchole (1:1, v/v). All solutions were freshly prepared, degassed and filtered through a 0.22-μm filter.
Liposome preparation
In order to prepare individual stock solutions, dry POPC, ergosterol and cholesterol were dissolved in chloroform. These stock solutions were prepared at the desired ratios: POPC/ ergosterol ( 
Formation of lipid bilayer membranes
The L1 sensor chip surface was washed by three injections of 15 μL of 20 mmol/L CHAPS at a flow rate of 30 μL/min. SUVs (80 μL) were immediately applied to the sensor chip at a flow rate of 10 μL/min for liposome capture for 500 s.
Fungizone binding to the bilayer membrane
Fungizone assay solutions were prepared by dissolving in PBS from 0.25 to 20 μmol/L (0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3.5, 5, 10, and 20 μmol/L). The Fungizone assay solution (100 μL, 200 s) was injected over the lipid surface at a flow rate of 30 μL/min to avoid limitation by mass transfer. On completion of injection, the buffer flow was continued to allow a dissociation time of 400 s. All binding experiments were carried out at 25 and 37 C. The affinity of Fungizone for the lipid bilayer membrane was determined from analysis of a series of response curves collected at six different Fungizone concentrations injected over each lipid surface in triplicate. After injection of the Fungizone assay solution, 15 μL of 100 mmol/L HCl/2-propylalchole (1:1, v/v) was injected at a flow rate of 30 μL/min to remove any captured liposome and Fungizone from the L1 sensor chip surface. This procedure ensured that liposome capture was freshly performed for each assay cycle, resulting in a sensor chip surface that could be recoated with fresh liposome containing the sterol for the next binding cycle.
Data analysis
The sensorgrams for each Fungizone-lipid interaction were analyzed by curve fitting using numerical integration analysis (1.5 -10 μmol/L).
The data were fitted globally by simultaneously fitting the Fungizone sensorgrams obtained at six different concentrations using BIA evaluation software (Ver. 4.1). The two-state reaction model was applied to the resultant Fungizone binding curves to estimate the association and dissociation rate constants. We chose this model on the basis of results of previous studies on AmB-membrane interactions. [27] [28] [29] [30] This model describes two steps, which in terms of the Fungizone-lipid interaction would correspond to:
Here F is Fungizone, L the lipid membrane, FL the initial complex formed by the lipid membrane and Fungizone via, for example, an electrostatic interaction. The complex FL changes to FL*, which cannot dissociate directly to F + L, and which may correspond to the insertion of Fungizone into the lipid bilayer.
The corresponding differential rate equations for this reaction model are represented by: [31] [32] [33] [34] [35] [36] 
where Rmax is maximum analyte binding capacity; R1 complex 1, which means formed by binding F to L; and R2 complex 2, which means formed by conformational change from FL. The association (ka1, ka2) and dissociation (kd1, kd2) rate constants and the affinity constant (K) estimated by the two-state reaction model are represented by:
Results and Discussion
Optimization of immobilization of model lipid membranes on the L1 sensor chip
In this SPR study, two different liposome mixtures were used as model lipid systems. A POPC/cholesterol (4:1, v/v) mixture was used to mimic mammalian membranes, while a POPC/ ergosterol (4:1, v/v) mixture was used as a fungal membrane system. 18, 26 The liposome mixture was prepared using PBS, isotonic dextrose solution, and water for injection in an effort to establish deal conditions to conduct steady liposome capture on the L1 chip. Also, these solutions were chosen because PBS is a typical buffer used for liposome preparation and other solutions are described as solutions for preparation of therapeutic medications in the Ethical Drug Package Insert of Fungizone. Next, the liposome mixtures were immobilized on the L1 chip respectively. As a result, the optimal immobilization condition for liposomes on the L1 chip could be conducted using the liposome mixture prepared by PBS. The response units (RU) of each lipid membrane immobilized on the L1 chip were measured on two separate experimental days (n = 18); and the average RU, standard deviation and relative standard deviation for each lipid type are listed in Table 1 . The results of the RU levels of lipid immobilized on the L1 chip and the relative standard deviations in RU for all lipids demonstrated a high level of reproducibility of the immobilization of lipid membranes on the sensor chip for a kinetics binding assay. 21 There appeared to be a small difference of RU immobilized on the L1 chip between POPC/cholesterol (4:1, v/v) and POPC/ergosterol (4:1, v/v), of approximately 5%. We judged that this small difference of immobilization of liposomes would not affect the estimation of interactions with the two membranes, considering the variation of affinity constant, including the constant rates in this study and our previous data for immobilization of various lipid membranes on the L1 chip. 21 
Interaction of Fungizone with lipid membrane
The antibiotic activity of AmB is attributed to a higher affinity for ergosterol, a primary fungal sterol, than for cholesterol in the mammalian membranes. The association (ka1, ka2) and dissociation (kd1, kd2) constants and the affinity constant (K) at 25 C (the system setting temperature) estimated by the two-state reaction model are listed in Table 2 . The reproducibility of each parameter by repeated assay was good. This model was selected based on the multistep model of AmB-lipid interactions, which may involve the initial binding interaction between Fungizone and the head group of the liposome (step 1, characterized by ka1, kd1), including the electrostatic interaction, and followed by a reorientation and/or insertion of the analyte into the hydrophobic interior (step 2, characterized by ka2, kd2) as previously described. [27] [28] [29] [30] In this model, the values of ka1/kd1 and ka2/kd2 correspond to the affinity constants for the initial binding interaction, including the electrostatic and hydrophobic interactions between Fungizone and the lipid membrane. The results of the kinetic analysis repeatedly showed only approximately 2-fold higher affinity constant of Fungizone for POPC/ergosterol (4:1, v/v) versus POPC/cholesterol (4:1, v/v), despite differences in the shape of the sensorgrams and binding response. The affinity of the first step of interaction of Fungizone to the head group of liposome showed an approximately 3-fold difference between the two membranes, and the affinity to ergosterol-containing membrane was slightly stronger. On the other hand, the values of hydrophobic association rate in the second step were significantly different for the two membranes, indicating that the force of hydrophobic insertion of Fungizone to the cholesterol-containing membrane was approximately 265-fold stronger than that of the ergosterolcontaining membrane. Furthermore, the value of the dissociation rate (kd2) of Fungizone to the ergosterol-containing membrane in the second step was approximately 6-fold lower than that of the cholesterol-containing membrane. The results indicated that Fungizone could dissociate to the cholesterol-containing membrane faster, although the association rate of Fungizone to the cholesterol-containing membrane is also fast and both the association rate and the dissociation rate of Fungizone to the ergosterol-containing membrane is slow. In fact the affinities of Fungizone to the lipid membranes are almost the same degree in totality.
Binding characteristic of additive and temperature dependence for the lipid membrane-binding of Fungizone by SPR
Fungizone is a drug product that incorporates AmB in deoxycholate micelles (as a medicinal additive) to address the solubility issue. A medicinal additive is also added to the drug substance in order to improve the characters of the drug substance for its effect on target diseases. For the SPR interaction study of drug products, it is necessary to consider the characteristics of additives in drug substances for the estimation of drug product interactions. In the case of Fungizone, it has a high concentration of sodium deoxycholate as the medicinal additive and the influence of the sodium deoxycholate on the estimation of the lipid membrane interaction of Fungizone in the SPR system should be considered. Also the interaction of drug products with the lipid membrane was also investigated at the physiological temperature (37 C), which would be the effective condition in vivo. Table 2 Association (ka1 and ka2), dissociation (kd1 and kd2) rate constants and affinity constant (K) determined by numerical integration using the two-state reaction model (n = 3) at 25 C First, we investigated the influence of sodium deoxycholate on the drug-lipid membrane interaction. Sodium deoxycholate (2.7 -18 μmol/L), corresponding to that contained in Fungizone over the concentration (1.5 -10 μmol/L) for estimation of interactions, was introduced into the lipid membrane SPR system under conventional conditions (assay temperature 25 C) and physiological conditions (assay temperature 37 C). Figure 3 shows representative sensorgrams of the binding of sodium deoxycholate to the immobilized POPC/ergosterol (4:1, v/v) and POPC/cholesterol (4:1, v/v) on the chip. The sensorgrams indicate that the interaction of sodium deoxycholate with the lipid membrane had no selectivity for the two types of lipid membranes at both temperatures and its binding ability was markedly weaker than those of Fungizone. Our studies showed that the characteristics of lipid membrane interaction of deoxycholate did not affect the estimation of membrane selectivity of Fungizone at either temperature.
Next, the affinities of Fungizone to the lipid membranes were estimated at the physiological condition (37 C).
The immobilization of POPC/ergosterol (4:1, v/v) and POPC/ cholesterol (4:1, v/v) on the intact L1 chip was examined at 37 C before the interaction between Fungizone and the lipid membrane was measured. The RU of each lipid membrane immobilized on the L1 chip were measured on two separate experimental days (n = 18), and the average RU, standard deviation and relative standard deviation for each lipid type are shown in Table 3 . The reproducibility of lipid membrane immobilized by repeated assay was good. Table 4 . The reproducibility of each parameter by repeated assay was good. The affinity constant K (mol -1 ·L) decreased from 3.12 × 10 5 to 1.83 × 10 5 for the ergosterol-containing membrane and from 1.70 × 10 5 to 0.619 × 10 5 for the cholesterol-containing membrane, respectively, indicating that the selectivity for the ergosterol-containing membrane by change of temperature was slightly higher than for the cholesterol-containing membrane. One reason for the change of affinity constants could be attributed to the drastic increase of the association constant in step 2 (ka2) for the ergosterol-containing membrane, suggesting that the association ability of Fungizone to the ergosterolcontaining membrane would strengthen with an increase in temperature. The drastic increase of the association constant in step 2 is thought to be due to the smooth insertion of AmB into the membrane via the complex of deoxycholate micelles and the hydrophobic region of the lipid membrane. 41 Also the dissociation constants in step 1 and 2 (kd1, kd2) of the Fungizone to ergosterol-containing membrane increased substantially, indicating that the dissociation rate of Fungizone to the ergosterol-containing membrane would increase with an increase in temperature. In total, however, no obvious change of affinity Table 4 Association (ka1 and ka2), dissociation (kd1 and kd2) rate constants and affinity constant (K) determined by numerical integration using the two-state reaction model (n = 3) at 37 C constant by temperature could be observed for the affinity of Fungizone to the lipid membranes. On the other hand, the association and dissociation constant rates in each interaction step varied depending on temperature.
Comparison binding kinetics of Fungizone or AmB to fungal model lipid membrane
We reported the binding kinetics of AmB as a drug substance to lipid membranes in the previous study. 26 An approximately 18-fold selectivity to the ergosterol-containing membrane in the case of AmB was observed in the SPR system, while the selectivity of Fungizone to the ergosterol-containing membrane was observed to be only 2-fold higher than that for the cholesterol-containing membrane. The value of K of Fungizone to the ergostarol-containing membrane decreased by less than approximately one-ninth of that of AmB, suggesting that the interaction of AmB with the lipid membrane would decrease upon incorporation in deoxycholate micelles. The characteristics of Fungizone to the lipid membrane interactions by SPR indicated that the side effects of Fungizone could not be reduced due to the low selectivity of the ergosterol-containing membrane, compared to AmB.
26
Conclusions
We established the assay for the interaction of Fungizone as drug product including the medicinal additive with lipid membrane. The present assay showed satisfactory reproducibility of immobilization of the lipid membranes onto the sensor chip and the estimation of binding kinetics of Fungizone to the lipid membranes by temperature dependence. We also demonstrated that the affinity parameter and selectivity of Fungizone for the lipid membrane were affected by changing the assay temperature. Furthermore, it was confirmed that the sodium deoxycholate, the major medicinal additive of Fungizone, did not influence the estimation of interaction selectivity of Fungizone to lipid membranes.
When an analysis for the mechanisms of interactions with drug products are developed by SPR, we think it is important to consider the effect of the characteristics of major medicinal additives on the estimation of drug-membrane interactions, including the influence of assay conditions, for example, temperature. The established SPR method in this study can provide a useful strategy of developing assay for the estimation of drug product-lipid membrane interactions.
